Clinical Trial Update: Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether a nasal spray containing azelastine hydrochloride and fluticasone propionate (137/50 mcg) is clinically equivalent to Dymi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• AZELASTINE HYDROCHLORIDE (azelastine hydrochloride)
• DYMISTA (azelastine hydrochloride and fluticasone propionate)
• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: UNKNOWN